The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2025
Filed:
May. 24, 2021
Applicant:
Scholar Rock, Inc., Cambridge, MA (US);
Inventors:
Gregory J. Carven, Maynard, MA (US);
Thomas Schurpf, Cambridge, MA (US);
Katherine Turner, Acton, MA (US);
Assignee:
Scholar Rock, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2005.12); A61K 38/18 (2005.12); A61K 39/00 (2005.12); A61K 39/39 (2005.12); A61K 39/395 (2005.12); C07K 16/28 (2005.12); C12N 9/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/22 (2012.12); A61K 38/18 (2012.12); A61K 39/39 (2012.12); A61K 39/3955 (2012.12); C07K 16/28 (2012.12); C12N 9/00 (2012.12); A61K 2039/505 (2012.12); C07K 2317/32 (2012.12); C07K 2317/76 (2012.12); C07K 2317/92 (2012.12);
Abstract
ProTGFβ1-GARP complex-selective antibodies, polynucleotides capable of encoding the proTGFβ1-GARP complex-selective antibodies or antigen-binding fragments, cells expressing proTGFβ1-GARP complex-selective antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled proTGFβ1-GARP complex-selective antibodies or antigen-binding fragments may be used to enhance an immune response in a subject, for example, against a cancer.